Daniel D Shoemaker Insider Trading $FATE FATE THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel D Shoemaker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel D Shoemaker. Daniel D Shoemaker is Chief Research Officer in FATE THERAPEUTICS INC ($FATE) and Chief Scientific Officer in FATE THERAPEUTICS INC ($FATE) and Chief Technology Officer in FATE THERAPEUTICS INC ($FATE).
Daniel D Shoemaker in FATE THERAPEUTICS INC
Trading Symbol: FATEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Daniel D Shoemaker: Chief Scientific Officer, Chief Research Officer, Chief Technology Officer
Holdings: 94,722 shares
Current Value: $265,222
Latest Transaction: Mar 09 2021
$FATE Market Capitalization: $95.27M
$FATE Previous Close: $2.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Daniel D Shoemaker in FATE THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 86.70 | 800 | 69,360 | 73,020 | 73.8 K to 73 K (-1.08 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 85.50 | 2,900 | 247,956 | 73,820 | 76.7 K to 73.8 K (-3.78 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 84.20 | 2,728 | 229,705 | 76,720 | 79.4 K to 76.7 K (-3.43 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 83.46 | 2,480 | 206,989 | 79,448 | 81.9 K to 79.4 K (-3.03 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 81.60 | 2,993 | 244,224 | 81,928 | 84.9 K to 81.9 K (-3.52 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 80.73 | 5,174 | 417,722 | 84,921 | 90.1 K to 84.9 K (-5.74 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 79.58 | 4,627 | 368,236 | 90,095 | 94.7 K to 90.1 K (-4.88 %) |
Mar 09 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 78.60 | 3,298 | 259,236 | 94,722 | 98 K to 94.7 K (-3.36 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 109.65 | 871 | 95,509 | 83,609 | 84.5 K to 83.6 K (-1.03 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 110.76 | 1,050 | 116,296 | 84,480 | 85.5 K to 84.5 K (-1.23 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 111.62 | 1,332 | 148,673 | 85,530 | 86.9 K to 85.5 K (-1.53 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 114.76 | 151 | 17,328 | 86,862 | 87 K to 86.9 K (-0.17 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 115.80 | 872 | 100,977 | 87,013 | 87.9 K to 87 K (-0.99 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 117.15 | 2,451 | 287,144 | 87,885 | 90.3 K to 87.9 K (-2.71 %) |
Jan 12 2021 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 117.60 | 2,755 | 323,985 | 90,336 | 93.1 K to 90.3 K (-2.96 %) |
Nov 16 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 52.40 | 14,781 | 774,514 | 93,091 | 107.9 K to 93.1 K (-13.70 %) |
Nov 16 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 51.60 | 5,287 | 272,825 | 107,872 | 113.2 K to 107.9 K (-4.67 %) |
Nov 16 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 50.37 | 4,932 | 248,407 | 113,159 | 118.1 K to 113.2 K (-4.18 %) |
Sep 16 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 37.12 | 5,713 | 212,074 | 118,091 | 123.8 K to 118.1 K (-4.61 %) |
Sep 16 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 36.11 | 17,887 | 645,909 | 123,804 | 141.7 K to 123.8 K (-12.62 %) |
Sep 16 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 35.40 | 1,400 | 49,557 | 141,691 | 143.1 K to 141.7 K (-0.98 %) |
Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 21.99 | 90,000 | 1,979,100 | 90,000 | |
Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 20.70 | 5,700 | 117,986 | 143,091 | 148.8 K to 143.1 K (-3.83 %) |
Jan 10 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Grant | A | 0.00 | 25,000 | 0 | 148,791 | 123.8 K to 148.8 K (+20.20 %) |
Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | M | 2.90 | 25,000 | 72,500 | 98,800 | |
Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 20.34 | 100 | 2,034 | 123,791 | 123.9 K to 123.8 K (-0.08 %) |
Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 19.49 | 24,900 | 485,393 | 123,891 | 148.8 K to 123.9 K (-16.73 %) |
Jan 02 2020 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Buy | M | 2.90 | 25,000 | 72,500 | 148,791 | 123.8 K to 148.8 K (+20.20 %) |
Oct 16 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 14.29 | 11,800 | 168,593 | 123,791 | 135.6 K to 123.8 K (-8.70 %) |
Jun 28 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | M | 2.90 | 12,500 | 36,250 | 123,800 | |
Jun 28 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 20.21 | 12,500 | 252,610 | 135,591 | 148.1 K to 135.6 K (-8.44 %) |
Jun 28 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Buy | M | 2.90 | 12,500 | 36,250 | 148,091 | 135.6 K to 148.1 K (+9.22 %) |
Mar 29 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | M | 2.90 | 12,500 | 36,250 | 136,300 | |
Mar 29 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 16.94 | 12,500 | 211,703 | 135,591 | 148.1 K to 135.6 K (-8.44 %) |
Mar 29 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Buy | M | 2.90 | 12,500 | 36,250 | 148,091 | 135.6 K to 148.1 K (+9.22 %) |
Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 16.55 | 135,000 | 2,234,250 | 135,000 | |
Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Grant | A | 0.00 | 45,000 | 0 | 135,591 | 90.6 K to 135.6 K (+49.67 %) |
Jan 17 2018 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 6.55 | 186,000 | 1,218,300 | 186,000 | |
Oct 17 2017 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 4.08 | 700 | 2,856 | 90,591 | 91.3 K to 90.6 K (-0.77 %) |
Oct 17 2017 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Sell | S | 3.86 | 12,525 | 48,347 | 91,291 | 103.8 K to 91.3 K (-12.06 %) |
Jan 06 2017 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 2.73 | 150,000 | 409,500 | 150,000 | |
Jan 12 2016 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 2.90 | 148,800 | 431,520 | 148,800 | |
Jan 12 2016 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Grant | A | 0.00 | 9,388 | 0 | 103,816 | 94.4 K to 103.8 K (+9.94 %) |
Oct 16 2015 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Grant | A | 0.00 | 66,000 | 0 | 94,428 | 28.4 K to 94.4 K (+232.17 %) |
Jan 07 2015 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Research Offi ... | Option Exercise | A | 4.84 | 70,000 | 338,450 | 70,000 | |
Jan 07 2015 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Research Offi ... | Grant | A | 0.00 | 2,466 | 0 | 28,428 | 26 K to 28.4 K (+9.50 %) |
Apr 02 2014 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Technology Of ... | Sell | S | 10.57 | 400 | 4,227 | 25,962 | 26.4 K to 26 K (-1.52 %) |
Apr 02 2014 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Technology Of ... | Sell | S | 9.83 | 8,253 | 81,134 | 26,362 | 34.6 K to 26.4 K (-23.84 %) |
Jan 10 2014 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Technology Of ... | Option Exercise | A | 6.62 | 85,000 | 562,700 | 85,000 |
Page: 1